SlideShare a Scribd company logo
ACUTE TUBULAR NECROSIS
(ATN)
PRESENTER: DR.SOHAN BISWAS, DNB JR-2,
DEPARTMENT OF INTERNAL MEDICINE,
MAX SUPERSPECIALITY HOSPITAL
• Most common intrinsic cause of acute kidney injury
• Renal tubular cell damage and death
• Term ‘tubular necrosis’ is a misnomer, as true cellular necrosis is
usually minimal
• Acute tubular necrosis is precipitated by an acute ischemic or toxic
event or sepsis.
Ischemic-Induced Acute Tubular Necrosis:
-Any factor that leads to prerenal azotemia can lead to ischemic acute
tubular necrosis.
-Hypovolemic states such as diarrhoea, vomiting, bleeding, dehydration,
burns, renal losses via diuretics or osmotic diuresis, and third space
sequestration.
Ischemic-Induced Acute Tubular Necrosis:
-Oedematous states such as heart failure and cirrhosis cause reduced
kidney perfusion.
-Sepsis or anaphylaxis leads to systemic vasodilation.
-Coagulopathy, such as disseminated intravascular coagulation, can also
cause acute tubular necrosis.
Nephrotoxic-Induced Acute Tubular Necrosis:
• ENDOTOXINS MEDIATED:
--Heme pigment-containing proteins such as hemoglobin and myoglobin
--Crystal-induced nephropathy due to high cell turnover such as uric
acid, calcium phosphate crystals in the setting of ongoing malignancy
treatment
--Light chain accumulation in multiple myeloma
Nephrotoxic-Induced Acute Tubular Necrosis:
• EXOTOXIN MEDIATED:
• Drugs such as aminoglycoside, amphotericin B, radiocontrast media,
sulpha drugs, acyclovir, cisplatin, calcineurin inhibitors (tacrolimus,
cyclosporine), mTOR inhibitors (everolimus), intravenous
immunoglobulin etc..
Sepsis-Induced Acute Tubular Necrosis
• Systemic hypotension and renal hypoperfusion.
• Inflammatory cytokines and reactive oxygen species
• Bacterial toxins
HISTOLOGY
• Typical features of ATN include vacuolization and loss of brush border
in proximal tubular cells.
• Sloughing of tubular cells into the lumen leads to cast obstruction,
manifested by tubular dilation.
EVALUATION
• The workup is usually to differentiate acute tubular necrosis from
prerenal AKI and other causes of AKI
Ratio of Blood Urea Nitrogen to Creatinine
• In prerenal AKI the ratio may exceed 20:1 because of a disproportionate
increase in urea reabsorption resulting from elevated serum vasopressin
levels.
• Upper gastrointestinal tract bleeding, impaired protein anabolism (e.g.,
systemic corticosteroid administration), increased catabolism (e.g., sepsis),
and increased protein intake all raise BUN levels.
• Furthermore, diminished urea production from decreased protein intake
or underlying liver disease are associated with lower BUN levels.
Fractional Excretion of Sodium and Urea
• FENa = [U/S] Na / [U/S] Cr × 100%
• Basic premise is that renal tubular cells will reabsorb sodium in the
prerenal setting, whereas tubules damaged by ATN will not.
• FENa less than 1% is consistent with prerenal AKI, and FENa greater
than 3% is typical of ATN
• However, FENa may be less than 1% despite ATN in the setting of
sepsis, hemoglobinuria or myoglobinuria, radiocontrast exposure,
heart failure, and advanced cirrhosis
• Underlying CKD, diuretic use, recent intravenous fluid administration,
glycosuria, bicarbonaturia, and salt wasting disorders may be
associated with elevated FENa despite the presence of prerenal AKI
• Urea reabsorption, primarily occurring in proximal tubules, is less
affected by loop and thiazide diuretics, and the fractional excretion of
urea (FEUrea) may be an alternative to FENa in patients receiving
diuretics.
• The calculation of FEUrea is identical to that of FENa, and values less
than 35% favor prerenal AKI over ATN.
• Urinalysis (UA)
--In prerenal disease, the UA microscopy is normal or may contain hyaline
casts.
--UA of acute tubular necrosis - muddy brown casts
• Urine sodium concentration:
• This test determines whether kidney is trying to conserve sodium or lose
sodium due to tubular injury with values more than 40 to 50 mEq/L
indicating acute tubular necrosis and less than 20 mEq/L suggestive of
prerenal disease
URINE – MUDDY BROWN GRANULAR CASTS
• In hospitalized patients with AKI, the presence of more than 10
granular casts per low-power field had a positive predictive value of
100% for a final diagnosis of ATN
Kidney Biopsy
• Kidney biopsy is reserved for patients in whom prerenal and postrenal
AKI have been excluded and the cause of intrinsic AKI remains unclear
• Particularly useful when clinical assessment and laboratory
investigations suggest diagnoses other than ischemic or nephrotoxic
injury that may respond to disease specific therapy (e.g., vasculitis,
systemic lupus erythematosus, and AIN).
MANAGEMENT
• 1) Treatment of the underlying cause
• 2) Maintain Fluid balance/avoid pre-renal insult
• 3) Diuretics not indicated to convert oliguric AKI to non-oliguric
AKI(only indicated for fluid overload – may need RRT)
• 4) Avoid and stop all nephrotoxic drugs
• Indications for urgent dialysis in patients with ATN include the
following:
• Refractory fluid overload
• Severe hyperkalemia
• Signs of uremia (eg, pericarditis, encephalopathy, altered
mental status)
• Severe metabolic acidosis (pH < 7.1)
• In patients without an indication for dialysis, initiating renal
replacement therapy (RRT) prophylactically offers no benefit
over performing RRT as and when required. Several trials and
meta-analysis have shown no improvement in outcome with
early versus late RRT for patients with AKI
COMPLICATIONS OF ATN
• Volume overload
• Acid-base and electrolyte imbalances, especially Hyperkalemia,
acidosis, hyperphosphatemia, and hypocalcemia
• Uremia, leading to problems such as prolonged bleeding,
altered mental status, and pericardial disease
NEW BIOMARKERS
Neutrophil Gelatinase-Associated Lipocalin(NGAL)
• Widely expressed in a variety of adult human tissues, including prostate,
salivary gland, stomach, colon, trachea, lung, liver and kidney
• Major renal source of urinary NGAL is from the thick ascending limb and
collecting ducts.
• Non-specific plasma NGAL can be filtered through glomeruli and be absorbed
in the proximal tubules
• Thus, urine NGAL elevation could reflect the decreased absorption of filtered
NGAL due to dysfunction or injury in the proximal tubules and/or increased
NGAL release from the thick ascending limb and collecting ducts
• Dramatically upregulated following ischemic or nephrotoxic kidney injury.
• As early as 3h following the injury, elevated NGAL protein is detectable in the
urine
Liver-Type Fatty Acid-Binding Protein(L-FABP)
• Expressed in the proximal tubules.
• Urinary L-FABP levels increase almost immediately and peak within 6 h after
tubular injury
• Exact function of L-FABP is yet to be fully elucidated. It is however considered
a renal protective protein in general.
• It binds to and promotes the metabolism of fatty acids and possesses
antioxidant properties
Interleukin-18
• Pro-inflammatory cytokine formed in the proximal tubular cells.
• Urinary IL-18 is elevated following renal injury
• AKI patients with high urine IL-18 concentration could potentially benefit from
anti-IL-18 therapy, although its utility is yet to be validated
Urinary Insulin-Like Growth Factor-Binding Protein 7 and Tissue
Inhibitor of Metalloproteinase-2
• TIMP-2 and IGFBP-7 are inducers of G1 cell cycle arrest of renal tubular cells,
which occurs during the early period of cell injury caused by ischemic or
inflammatory processes
• Failure to achieve G1 cell cycle arrest can lead to an increased proportion of
renal tubular cells in the G2/M phase, which in the animal model shows to be
correlated with lasting kidney damage, including extensive glomerulosclerosis
and interstitial fibrosis
Serum and Urine Kidney Injury Molecule 1
• Very low expression in the normal kidney. Its expression is markedly
upregulated after ischemia-reperfusion injury.
• Reflects the proliferating dedifferentiated epithelial cells of the proximal
tubules and appears to peak at approximately 48 h
• Promotes epithelial regeneration and regulates tubule cell apoptosis.
• Persistent KIM-1 elevation in blood, however, indicates ongoing tubular injury,
which would be a risk for the development of CKD/ESRD.
• Urinary KIM-1 shows similar correlation of kidney injury
CLINICAL CASE – 1 (SEPSIS INDUCED ATN)
• Mrs. Johnson is brought to the emergency department by ambulance with a one-day
history of high fever, confusion, and decreased urine output. She has a known diabetic
foot ulcer for which she has been receiving outpatient wound care.
• Initial Assessment:
• Vital Signs: Blood pressure 90/60 mmHg, heart rate 120 bpm, respiratory rate 24
breaths/min, temperature 39.5°C.
• Physical Examination: Mrs. Johnson appears acutely ill and disoriented. She has cool
extremities with weak peripheral pulses. Lung examination reveals bilateral crackles. Her
foot ulcer shows signs of cellulitis with surrounding erythema and tenderness.
• Laboratory Investigations:
• Serum Creatinine: 4.0 mg/dL (baseline 1.0 mg/dL)
• Blood Urea Nitrogen (BUN): 50 mg/dL
• Serum Potassium: 5.6 mmol/L
• White Blood Cell Count: 20,000/mm³ with left shift
• Arterial Blood Gas (ABG): pH 7.32, pCO2 30 mmHg, HCO3- 18 mmol/L
• Urinalysis: Proteinuria (3+), muddy brown granular casts, few red blood cells, few white blood cells.
CLINICAL CASE – 2(NEPHROTOXIC INDUCED
ATN)
• Mr. Lee presents to the emergency department with complaints of nausea,
vomiting, and decreased urine output for the past two days. He reports recent
use of over-the-counter non-steroidal anti-inflammatory drugs (NSAIDs) for
worsening knee pain.
• Initial Assessment:
• Vital Signs: Blood pressure 140/90 mmHg, heart rate 80 bpm, respiratory rate
16 breaths/min, temperature 37.0°C.
• Physical Examination: Mr. Lee appears dehydrated and mildly lethargic. His
abdomen is soft and non-tender with no rebound tenderness. Lung and heart
examinations are unremarkable.
• Laboratory Investigations:
• Serum Creatinine: 3.5 mg/dL (baseline 1.0 mg/dL)
• Blood Urea Nitrogen (BUN): 45 mg/dL
• Serum Potassium: 5.2 mmol/L
• Urinalysis: Proteinuria (1+), muddy brown granular casts, few red blood cells, few white
blood cells.
CLINICAL CASE – 3(ISCHEMIA INDUCED ATN)
• Mr. Johnson is brought to the emergency department by ambulance following a motor
vehicle accident. He was found unconscious at the scene and is now awake but
confused. He complains of severe abdominal pain and has not passed urine since the
accident.
• Initial Assessment:
• Vital Signs: Blood pressure 90/60 mmHg, heart rate 110 bpm, respiratory rate 22
breaths/min, temperature 37.2°C.
• Physical Examination: Mr. Johnson appears lethargic and in distress. His abdomen is
tender on palpation, with guarding and rebound tenderness in the bilateral flanks. There
are no other significant findings on cardiovascular or respiratory examination.
• Laboratory Investigations:
• Serum Creatinine: 6.0 mg/dL (baseline unknown)
• Blood Urea Nitrogen (BUN): 70 mg/dL
• Serum Potassium: 6.2 mmol/L
• Arterial Blood Gas (ABG): pH 7.28, pCO2 30 mmHg, HCO3- 18 mmol/L
• Urinalysis: Proteinuria (3+), muddy brown granular casts, few red blood cells, few white blood cells.
THANK YOU

More Related Content

Similar to ACUTE TUBULAR NECROSIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx

Acute liver failure.pptx
Acute liver failure.pptxAcute liver failure.pptx
Acute liver failure.pptx
CutiePie71
 
The Medical Assessment and Management of Oliguria
The Medical Assessment and Management of OliguriaThe Medical Assessment and Management of Oliguria
The Medical Assessment and Management of Oliguria
Luis Daniel Lugo
 
ACUTE KIDNEY INJURY.pptx
ACUTE KIDNEY INJURY.pptxACUTE KIDNEY INJURY.pptx
ACUTE KIDNEY INJURY.pptx
Ivwananjisikombe1
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
Hasnein Mohamedali MD
 
1 Acute Kidney Injury.pptx
1 Acute Kidney Injury.pptx1 Acute Kidney Injury.pptx
1 Acute Kidney Injury.pptx
Sani42793
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
Revathy Ambikadevi
 
acuterenalfailure-.pptx
acuterenalfailure-.pptxacuterenalfailure-.pptx
acuterenalfailure-.pptx
bhavanibb
 
Acute kidney injury
Acute kidney injury Acute kidney injury
Acute kidney injury
anoop k r
 
AKI - Approach
AKI - ApproachAKI - Approach
AKI - Approach
Naveen Kumar
 
Acute Kidney Injury (AKI)
Acute Kidney Injury (AKI)Acute Kidney Injury (AKI)
Acute Kidney Injury (AKI)
Dr.mujahid Abdallah
 
hadout 3.ppt
hadout 3.ppthadout 3.ppt
hadout 3.ppt
TadesseFenta1
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
drriyaz95
 
Acute Kidney Injury
Acute Kidney InjuryAcute Kidney Injury
Acute Kidney Injury
Viquas Saim
 
AKI
AKIAKI
ACUTE RENAL FAILURE_FINAL PRESENTATION.pptx
ACUTE RENAL FAILURE_FINAL PRESENTATION.pptxACUTE RENAL FAILURE_FINAL PRESENTATION.pptx
ACUTE RENAL FAILURE_FINAL PRESENTATION.pptx
Aditya Sinha
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
Mouhmad Qasem
 
medicine.Acute renal failure.(dr.kawa)
medicine.Acute renal failure.(dr.kawa)medicine.Acute renal failure.(dr.kawa)
medicine.Acute renal failure.(dr.kawa)
student
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failure
MEEQAT HOSPITAL
 
Drug induced nephritis
Drug induced nephritis Drug induced nephritis
Drug induced nephritis
Joseph Openy
 
Acute kidney Injury today presenting dr. mohamed last 111111 (1).pptx
Acute kidney Injury today presenting dr. mohamed last 111111 (1).pptxAcute kidney Injury today presenting dr. mohamed last 111111 (1).pptx
Acute kidney Injury today presenting dr. mohamed last 111111 (1).pptx
wanzunulagerald
 

Similar to ACUTE TUBULAR NECROSIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx (20)

Acute liver failure.pptx
Acute liver failure.pptxAcute liver failure.pptx
Acute liver failure.pptx
 
The Medical Assessment and Management of Oliguria
The Medical Assessment and Management of OliguriaThe Medical Assessment and Management of Oliguria
The Medical Assessment and Management of Oliguria
 
ACUTE KIDNEY INJURY.pptx
ACUTE KIDNEY INJURY.pptxACUTE KIDNEY INJURY.pptx
ACUTE KIDNEY INJURY.pptx
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
1 Acute Kidney Injury.pptx
1 Acute Kidney Injury.pptx1 Acute Kidney Injury.pptx
1 Acute Kidney Injury.pptx
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
acuterenalfailure-.pptx
acuterenalfailure-.pptxacuterenalfailure-.pptx
acuterenalfailure-.pptx
 
Acute kidney injury
Acute kidney injury Acute kidney injury
Acute kidney injury
 
AKI - Approach
AKI - ApproachAKI - Approach
AKI - Approach
 
Acute Kidney Injury (AKI)
Acute Kidney Injury (AKI)Acute Kidney Injury (AKI)
Acute Kidney Injury (AKI)
 
hadout 3.ppt
hadout 3.ppthadout 3.ppt
hadout 3.ppt
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
Acute Kidney Injury
Acute Kidney InjuryAcute Kidney Injury
Acute Kidney Injury
 
AKI
AKIAKI
AKI
 
ACUTE RENAL FAILURE_FINAL PRESENTATION.pptx
ACUTE RENAL FAILURE_FINAL PRESENTATION.pptxACUTE RENAL FAILURE_FINAL PRESENTATION.pptx
ACUTE RENAL FAILURE_FINAL PRESENTATION.pptx
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
medicine.Acute renal failure.(dr.kawa)
medicine.Acute renal failure.(dr.kawa)medicine.Acute renal failure.(dr.kawa)
medicine.Acute renal failure.(dr.kawa)
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failure
 
Drug induced nephritis
Drug induced nephritis Drug induced nephritis
Drug induced nephritis
 
Acute kidney Injury today presenting dr. mohamed last 111111 (1).pptx
Acute kidney Injury today presenting dr. mohamed last 111111 (1).pptxAcute kidney Injury today presenting dr. mohamed last 111111 (1).pptx
Acute kidney Injury today presenting dr. mohamed last 111111 (1).pptx
 

More from Dr. Sohan Biswas

VIRAL ENCEPHALITIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
VIRAL ENCEPHALITIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxVIRAL ENCEPHALITIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
VIRAL ENCEPHALITIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
Dr. Sohan Biswas
 
PLASMAPHERESIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
PLASMAPHERESIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxPLASMAPHERESIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
PLASMAPHERESIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
Dr. Sohan Biswas
 
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
Dr. Sohan Biswas
 
ADRENAL INSUFFICIENCY BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT...
ADRENAL INSUFFICIENCY BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT...ADRENAL INSUFFICIENCY BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT...
ADRENAL INSUFFICIENCY BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT...
Dr. Sohan Biswas
 
PROLACTINOMA BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
PROLACTINOMA BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxPROLACTINOMA BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
PROLACTINOMA BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
Dr. Sohan Biswas
 
PCOD BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
PCOD BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxPCOD BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
PCOD BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
Dr. Sohan Biswas
 

More from Dr. Sohan Biswas (6)

VIRAL ENCEPHALITIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
VIRAL ENCEPHALITIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxVIRAL ENCEPHALITIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
VIRAL ENCEPHALITIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
 
PLASMAPHERESIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
PLASMAPHERESIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxPLASMAPHERESIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
PLASMAPHERESIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
 
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
 
ADRENAL INSUFFICIENCY BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT...
ADRENAL INSUFFICIENCY BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT...ADRENAL INSUFFICIENCY BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT...
ADRENAL INSUFFICIENCY BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT...
 
PROLACTINOMA BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
PROLACTINOMA BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxPROLACTINOMA BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
PROLACTINOMA BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
 
PCOD BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
PCOD BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxPCOD BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
PCOD BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
 

Recently uploaded

Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 

Recently uploaded (20)

Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 

ACUTE TUBULAR NECROSIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx

  • 1. ACUTE TUBULAR NECROSIS (ATN) PRESENTER: DR.SOHAN BISWAS, DNB JR-2, DEPARTMENT OF INTERNAL MEDICINE, MAX SUPERSPECIALITY HOSPITAL
  • 2. • Most common intrinsic cause of acute kidney injury • Renal tubular cell damage and death • Term ‘tubular necrosis’ is a misnomer, as true cellular necrosis is usually minimal • Acute tubular necrosis is precipitated by an acute ischemic or toxic event or sepsis.
  • 3.
  • 4.
  • 5. Ischemic-Induced Acute Tubular Necrosis: -Any factor that leads to prerenal azotemia can lead to ischemic acute tubular necrosis. -Hypovolemic states such as diarrhoea, vomiting, bleeding, dehydration, burns, renal losses via diuretics or osmotic diuresis, and third space sequestration.
  • 6. Ischemic-Induced Acute Tubular Necrosis: -Oedematous states such as heart failure and cirrhosis cause reduced kidney perfusion. -Sepsis or anaphylaxis leads to systemic vasodilation. -Coagulopathy, such as disseminated intravascular coagulation, can also cause acute tubular necrosis.
  • 7. Nephrotoxic-Induced Acute Tubular Necrosis: • ENDOTOXINS MEDIATED: --Heme pigment-containing proteins such as hemoglobin and myoglobin --Crystal-induced nephropathy due to high cell turnover such as uric acid, calcium phosphate crystals in the setting of ongoing malignancy treatment --Light chain accumulation in multiple myeloma
  • 8. Nephrotoxic-Induced Acute Tubular Necrosis: • EXOTOXIN MEDIATED: • Drugs such as aminoglycoside, amphotericin B, radiocontrast media, sulpha drugs, acyclovir, cisplatin, calcineurin inhibitors (tacrolimus, cyclosporine), mTOR inhibitors (everolimus), intravenous immunoglobulin etc..
  • 9. Sepsis-Induced Acute Tubular Necrosis • Systemic hypotension and renal hypoperfusion. • Inflammatory cytokines and reactive oxygen species • Bacterial toxins
  • 10. HISTOLOGY • Typical features of ATN include vacuolization and loss of brush border in proximal tubular cells. • Sloughing of tubular cells into the lumen leads to cast obstruction, manifested by tubular dilation.
  • 11.
  • 12. EVALUATION • The workup is usually to differentiate acute tubular necrosis from prerenal AKI and other causes of AKI
  • 13.
  • 14. Ratio of Blood Urea Nitrogen to Creatinine • In prerenal AKI the ratio may exceed 20:1 because of a disproportionate increase in urea reabsorption resulting from elevated serum vasopressin levels. • Upper gastrointestinal tract bleeding, impaired protein anabolism (e.g., systemic corticosteroid administration), increased catabolism (e.g., sepsis), and increased protein intake all raise BUN levels. • Furthermore, diminished urea production from decreased protein intake or underlying liver disease are associated with lower BUN levels.
  • 15. Fractional Excretion of Sodium and Urea • FENa = [U/S] Na / [U/S] Cr × 100% • Basic premise is that renal tubular cells will reabsorb sodium in the prerenal setting, whereas tubules damaged by ATN will not. • FENa less than 1% is consistent with prerenal AKI, and FENa greater than 3% is typical of ATN
  • 16. • However, FENa may be less than 1% despite ATN in the setting of sepsis, hemoglobinuria or myoglobinuria, radiocontrast exposure, heart failure, and advanced cirrhosis • Underlying CKD, diuretic use, recent intravenous fluid administration, glycosuria, bicarbonaturia, and salt wasting disorders may be associated with elevated FENa despite the presence of prerenal AKI
  • 17. • Urea reabsorption, primarily occurring in proximal tubules, is less affected by loop and thiazide diuretics, and the fractional excretion of urea (FEUrea) may be an alternative to FENa in patients receiving diuretics. • The calculation of FEUrea is identical to that of FENa, and values less than 35% favor prerenal AKI over ATN.
  • 18. • Urinalysis (UA) --In prerenal disease, the UA microscopy is normal or may contain hyaline casts. --UA of acute tubular necrosis - muddy brown casts • Urine sodium concentration: • This test determines whether kidney is trying to conserve sodium or lose sodium due to tubular injury with values more than 40 to 50 mEq/L indicating acute tubular necrosis and less than 20 mEq/L suggestive of prerenal disease
  • 19. URINE – MUDDY BROWN GRANULAR CASTS • In hospitalized patients with AKI, the presence of more than 10 granular casts per low-power field had a positive predictive value of 100% for a final diagnosis of ATN
  • 20. Kidney Biopsy • Kidney biopsy is reserved for patients in whom prerenal and postrenal AKI have been excluded and the cause of intrinsic AKI remains unclear • Particularly useful when clinical assessment and laboratory investigations suggest diagnoses other than ischemic or nephrotoxic injury that may respond to disease specific therapy (e.g., vasculitis, systemic lupus erythematosus, and AIN).
  • 21. MANAGEMENT • 1) Treatment of the underlying cause • 2) Maintain Fluid balance/avoid pre-renal insult • 3) Diuretics not indicated to convert oliguric AKI to non-oliguric AKI(only indicated for fluid overload – may need RRT) • 4) Avoid and stop all nephrotoxic drugs
  • 22. • Indications for urgent dialysis in patients with ATN include the following: • Refractory fluid overload • Severe hyperkalemia • Signs of uremia (eg, pericarditis, encephalopathy, altered mental status) • Severe metabolic acidosis (pH < 7.1)
  • 23. • In patients without an indication for dialysis, initiating renal replacement therapy (RRT) prophylactically offers no benefit over performing RRT as and when required. Several trials and meta-analysis have shown no improvement in outcome with early versus late RRT for patients with AKI
  • 24. COMPLICATIONS OF ATN • Volume overload • Acid-base and electrolyte imbalances, especially Hyperkalemia, acidosis, hyperphosphatemia, and hypocalcemia • Uremia, leading to problems such as prolonged bleeding, altered mental status, and pericardial disease
  • 26. Neutrophil Gelatinase-Associated Lipocalin(NGAL) • Widely expressed in a variety of adult human tissues, including prostate, salivary gland, stomach, colon, trachea, lung, liver and kidney • Major renal source of urinary NGAL is from the thick ascending limb and collecting ducts. • Non-specific plasma NGAL can be filtered through glomeruli and be absorbed in the proximal tubules
  • 27. • Thus, urine NGAL elevation could reflect the decreased absorption of filtered NGAL due to dysfunction or injury in the proximal tubules and/or increased NGAL release from the thick ascending limb and collecting ducts • Dramatically upregulated following ischemic or nephrotoxic kidney injury. • As early as 3h following the injury, elevated NGAL protein is detectable in the urine
  • 28. Liver-Type Fatty Acid-Binding Protein(L-FABP) • Expressed in the proximal tubules. • Urinary L-FABP levels increase almost immediately and peak within 6 h after tubular injury • Exact function of L-FABP is yet to be fully elucidated. It is however considered a renal protective protein in general. • It binds to and promotes the metabolism of fatty acids and possesses antioxidant properties
  • 29. Interleukin-18 • Pro-inflammatory cytokine formed in the proximal tubular cells. • Urinary IL-18 is elevated following renal injury • AKI patients with high urine IL-18 concentration could potentially benefit from anti-IL-18 therapy, although its utility is yet to be validated
  • 30. Urinary Insulin-Like Growth Factor-Binding Protein 7 and Tissue Inhibitor of Metalloproteinase-2 • TIMP-2 and IGFBP-7 are inducers of G1 cell cycle arrest of renal tubular cells, which occurs during the early period of cell injury caused by ischemic or inflammatory processes • Failure to achieve G1 cell cycle arrest can lead to an increased proportion of renal tubular cells in the G2/M phase, which in the animal model shows to be correlated with lasting kidney damage, including extensive glomerulosclerosis and interstitial fibrosis
  • 31. Serum and Urine Kidney Injury Molecule 1 • Very low expression in the normal kidney. Its expression is markedly upregulated after ischemia-reperfusion injury. • Reflects the proliferating dedifferentiated epithelial cells of the proximal tubules and appears to peak at approximately 48 h • Promotes epithelial regeneration and regulates tubule cell apoptosis.
  • 32. • Persistent KIM-1 elevation in blood, however, indicates ongoing tubular injury, which would be a risk for the development of CKD/ESRD. • Urinary KIM-1 shows similar correlation of kidney injury
  • 33. CLINICAL CASE – 1 (SEPSIS INDUCED ATN) • Mrs. Johnson is brought to the emergency department by ambulance with a one-day history of high fever, confusion, and decreased urine output. She has a known diabetic foot ulcer for which she has been receiving outpatient wound care. • Initial Assessment: • Vital Signs: Blood pressure 90/60 mmHg, heart rate 120 bpm, respiratory rate 24 breaths/min, temperature 39.5°C. • Physical Examination: Mrs. Johnson appears acutely ill and disoriented. She has cool extremities with weak peripheral pulses. Lung examination reveals bilateral crackles. Her foot ulcer shows signs of cellulitis with surrounding erythema and tenderness. • Laboratory Investigations: • Serum Creatinine: 4.0 mg/dL (baseline 1.0 mg/dL) • Blood Urea Nitrogen (BUN): 50 mg/dL • Serum Potassium: 5.6 mmol/L • White Blood Cell Count: 20,000/mm³ with left shift • Arterial Blood Gas (ABG): pH 7.32, pCO2 30 mmHg, HCO3- 18 mmol/L • Urinalysis: Proteinuria (3+), muddy brown granular casts, few red blood cells, few white blood cells.
  • 34. CLINICAL CASE – 2(NEPHROTOXIC INDUCED ATN) • Mr. Lee presents to the emergency department with complaints of nausea, vomiting, and decreased urine output for the past two days. He reports recent use of over-the-counter non-steroidal anti-inflammatory drugs (NSAIDs) for worsening knee pain. • Initial Assessment: • Vital Signs: Blood pressure 140/90 mmHg, heart rate 80 bpm, respiratory rate 16 breaths/min, temperature 37.0°C. • Physical Examination: Mr. Lee appears dehydrated and mildly lethargic. His abdomen is soft and non-tender with no rebound tenderness. Lung and heart examinations are unremarkable. • Laboratory Investigations: • Serum Creatinine: 3.5 mg/dL (baseline 1.0 mg/dL) • Blood Urea Nitrogen (BUN): 45 mg/dL • Serum Potassium: 5.2 mmol/L • Urinalysis: Proteinuria (1+), muddy brown granular casts, few red blood cells, few white blood cells.
  • 35. CLINICAL CASE – 3(ISCHEMIA INDUCED ATN) • Mr. Johnson is brought to the emergency department by ambulance following a motor vehicle accident. He was found unconscious at the scene and is now awake but confused. He complains of severe abdominal pain and has not passed urine since the accident. • Initial Assessment: • Vital Signs: Blood pressure 90/60 mmHg, heart rate 110 bpm, respiratory rate 22 breaths/min, temperature 37.2°C. • Physical Examination: Mr. Johnson appears lethargic and in distress. His abdomen is tender on palpation, with guarding and rebound tenderness in the bilateral flanks. There are no other significant findings on cardiovascular or respiratory examination. • Laboratory Investigations: • Serum Creatinine: 6.0 mg/dL (baseline unknown) • Blood Urea Nitrogen (BUN): 70 mg/dL • Serum Potassium: 6.2 mmol/L • Arterial Blood Gas (ABG): pH 7.28, pCO2 30 mmHg, HCO3- 18 mmol/L • Urinalysis: Proteinuria (3+), muddy brown granular casts, few red blood cells, few white blood cells.